RoundTable Healthcare Partners Completes Sale of Revision Skincare and Goodier Cosmetics to Gryphon Investors

Terms of the transaction were not disclosed.

RoundTable Healthcare Partners completed the previously announced sale of Revision Skincare and Goodier Cosmetics to Gryphon Investors. 

Terms of the transaction were not disclosed.

Revision Skincare’s portfolio includes Nectifirm, Intellishade, D·E·J and Revox.

Goodier Cosmetics is a leading topical contract development and manufacturing company. Goodier's customers include high-growth emerging brands as well as established market-leading skincare brands.

"On behalf of RoundTable and our investors, I would like to thank the outstanding management team and dedicated employees of Revision Goodier for helping to create such a valuable business," says Pierre Frechette, Managing Partner of RoundTable and Chairman of Revision Goodier, in a news release. "We believe that Gryphon will be an excellent partner for the Company and its employees and customers going forward."

Maria Carell, Chief Executive Officer of Revision Goodier, adds, "RoundTable has been a tremendous partner for Revision Goodier since their initial acquisition of the Company in 2016. They have supported strategic investments in the Company to meaningfully accelerate our organic revenue and earnings growth. We now look forward to entering our next phase of growth with Gryphon." Here more from Carell on the acquistion on the latest edition of MATV.

Financo Raymond James acted as exclusive financial advisor to Revision Goodier, and Sidley Austin LLP acted as exclusive legal advisor to RoundTable in this transaction.

RoundTable Healthcare Partners, based in Lake Forest, IL, is an operating-oriented private equity firm focused exclusively on the healthcare industry. RoundTable has raised $3.45 billion in committed capital, including five equity funds totaling $2.85 billion and three subordinated debt funds totaling $600 million.